Nope it is for severe patients (using the common definition found in most studies in the litterature), which is not nothing. This is precisely the vast majority of patients reaching hospitals (criticals being a minority). This potential treatment is spot on.
I mentioned in post 179516 that our “moderately ill” in Brazil includes a large subgroup of those considered Critical in cd12. Only ECMO level patients fall in Critical category in Brazil.
If that is correct, then yes from the standpoint of LL, the distinctions we presently have for these categories apply at a later stage of the disease, and it will not be appropriate to conflate our “moderately ill” with what others consider severe.